Diabetes Archives - Page 6 of 7 - Infectious Disease Advisor

Rising Incidence of Diabetes in Adults With HIV on Antiretroviral Therapy

By

March 27, 2018

More research is needed to better capture the interplay between prediabetes/diabetes and antiretroviral therapy in people with HIV.

In-Depth Focus from IDWeek 2017: Skin Infections

Omadacycline Noninferior to Linezolid in ABSSSI Patients With High BMI, Diabetes

By

Brandon May

October 26, 2017

The goal of this post-hoc analysis of OASIS-1 study was to determine if BMI or T2D had any effect on the efficacy or safety of omadacycline relative to linezolid.

In-Depth Focus from IDWeek 2017: Skin Infections

Treating ABSSSI in Diabetes: Efficacy of Dalbavancin Examined

By

Haymarket Media

October 20, 2017

Dalbavancin has shown potent activity against gram-positive pathogens responsible for ABSSSI, including MRSA.

Respiratory

Metformin Reduces Mortality During Tuberculosis Therapy

By

Jessica Martin

October 12, 2017

Researchers assess all-cause mortality during tuberculosis treatment in patients with diabetes, the use of metformin, and effect sputum culture-conversion rates.

Hepatitis

Does Sustained Virologic Response Improve Glycemic Control in HCV?

By

Charlotte Galper

September 29, 2017

Researchers compared HbA1c changes and use of antidiabetic medication in HCV with diabetes.

Study Identifies Metformin's Potential Role in Atherosclerosis

HIV/AIDS

Does ART Increase Risk of Diabetes in HIV-infected Patients?

By

Haymarket Media

July 12, 2017

Antiretroviral therapy may be the most consistent determinant of diabetes in patients with HIV.

Nosocomial Infections

Burden of Care Greater With Diabetic Foot Ulcers and Infections

June 7, 2017

Study investigated an estimated 6.7 million diabetic foot cases and the risk for emergency department or inpatient admissions and number of outpatient visits.

Hepatitis

Hepatitis C Virus Infection: A Risk Factor for Type 2 Diabetes?

By

Crystal Wong, MD

June 5, 2017

Hepatitis C virus infection may increase the risk for type 2 diabetes, but whether a causal relationship exists is unclear. Screening for type 2 diabetes in this population may have important public health implications.

Pneumonia

Higher Risk of Community-Acquired Pneumonia With Certain T2D Drugs

By

Steve Duffy

April 26, 2017

Patients with type 2 diabetes may be at greater risk of developing community-acquired pneumonia when using thiazolidinediones with metformin compared to treatment with a sulfonylurea and metformin.